Nj. Wesensten et al., EFFECTS OF DAYTIME ADMINISTRATION OF ZOLPIDEM VERSUS TRIAZOLAM ON MEMORY, European Journal of Clinical Pharmacology, 48(2), 1995, pp. 115-122
To determine whether zolpidem (an imidazopyridine hypnotic) produces a
mnestic effects which are similar to those produced by triazolam (a be
nzodiazepine hypnotic), 70 subjects were adminstered either triazolam
(0.125, 0.25, or 0.5 mg), zolpidem (5, 10 or 15 mg) or placebo, then t
ested on Simulated Escape, Restricted Reminding, and Paired-Associates
memory tests at 1.5 hours post-dosing (i.e., near the time of estimat
ed peak blood concentration for both drugs) and again at 6 hours post-
dosing. Triazolam 0.5 mg produced the greatest memory impairment at bo
th test times, and also produced the greatest degree of sedation durin
g intervening daytime naps in a non-sleep-conducive environment. Other
doses of triazolam and zolpidem produced less memory impairment, but
also failed to significantly enhance sleep. The results are consistent
with the view that the amnestic and hypnotic effects of these sleep-i
nducing medications are functionally coupled.